Half-year report · Q2
7730.TEDINET S100VLRW
Period2024-09-01 → 2025-02-28
Filed2025-04-11
StandardJapan GAAP
ConsolidatedYes
Data checks14 of 14 passed
Key figures · 44
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥14.8bn | 2024-09-01 → 2025-02-28 | Cons. | Net sales |
| Revenue | ¥28.5bn | 2023-09-01 → 2024-08-31 | Cons. | Net sales (5-year summary) |
| Revenue | ¥13.9bn | 2023-09-01 → 2024-02-29 | Cons. | Net sales |
| Operating income | ¥4.2bn | 2024-09-01 → 2025-02-28 | Cons. | Operating income |
| Operating income | ¥4.2bn | 2023-09-01 → 2024-02-29 | Cons. | Operating income |
| Ordinary income | ¥4.3bn | 2024-09-01 → 2025-02-28 | Cons. | Ordinary income |
| Ordinary income | ¥8.5bn | 2023-09-01 → 2024-08-31 | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥4.6bn | 2023-09-01 → 2024-02-29 | Cons. | Ordinary income |
| Profit before tax | ¥4.3bn | 2024-09-01 → 2025-02-28 | Cons. | Income before income taxes |
| Profit before tax | ¥4.5bn | 2023-09-01 → 2024-02-29 | Cons. | Income before income taxes |
| Net income (owners) | ¥2.9bn | 2024-09-01 → 2025-02-28 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥6.3bn | 2023-09-01 → 2024-08-31 | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥3.2bn | 2023-09-01 → 2024-02-29 | Cons. | Profit loss attributable to owners of parent |
| Net income | ¥2.9bn | 2024-09-01 → 2025-02-28 | Cons. | Profit loss |
| Net income | ¥3.2bn | 2023-09-01 → 2024-02-29 | Cons. | Profit loss |
| Total assets | ¥58.3bn | at 2025-02-28 | Cons. | Assets |
| Total assets | ¥57.2bn | at 2024-08-31 | Cons. | Assets |
| Total assets | ¥56.2bn | at 2024-02-29 | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥4.9bn | at 2025-02-28 | Cons. | Liabilities |
| Total liabilities | ¥4.8bn | at 2024-08-31 | Cons. | Liabilities |
| Net assets / equity | ¥53.4bn | at 2025-02-28 | Cons. | Net assets |
| Net assets / equity | ¥52.3bn | at 2024-08-31 | Cons. | Net assets |
| Net assets / equity | ¥51.6bn | at 2024-02-29 | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥18.3bn | at 2025-02-28 | Cons. | Cash and deposits |
| Cash and deposits | ¥21.6bn | at 2024-08-31 | Cons. | Cash and deposits |
| Cash & equivalents | ¥17.5bn | at 2025-02-28 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥21.0bn | at 2024-08-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥22.7bn | at 2024-02-29 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥23.8bn | at 2023-08-31d | Cons. | Cash and cash equivalents |
| Operating cash flow | ¥3.0bn | 2024-09-01 → 2025-02-28 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥7.8bn | 2023-09-01 → 2024-08-31 | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥3.6bn | 2023-09-01 → 2024-02-29 | Cons. | Net cash provided by used in operating activities |
| Investing cash flow | −¥4.6bn | 2024-09-01 → 2025-02-28 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥6.6bn | 2023-09-01 → 2024-08-31 | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥3.1bn | 2023-09-01 → 2024-02-29 | Cons. | Net cash provided by used in investment activities |
| Financing cash flow | −¥2.3bn | 2024-09-01 → 2025-02-28 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | −¥3.7bn | 2023-09-01 → 2024-08-31 | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | −¥2.1bn | 2023-09-01 → 2024-02-29 | Cons. | Net cash provided by used in financing activities |
| EPS (basic) | ¥29.85 | 2024-09-01 → 2025-02-28 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥63.82 | 2023-09-01 → 2024-08-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥32.41 | 2023-09-01 → 2024-02-29 | Cons. | Basic earnings loss per share (5-year summary) |
| Equity ratio | 91.6% | at 2025-02-28 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 91.5% | at 2024-08-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 91.8% | at 2024-02-29 | Cons. | Equity to asset ratio (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 32
| Segment | Item | Period | Value |
|---|---|---|---|
| Reconciling Itemsreconciling | revenue | 2024-09-01 → 2025-02-28 | ¥0 |
| Reconciling Itemsreconciling | revenue intersegment | 2024-09-01 → 2025-02-28 | ¥0 |
| jpcrp040300-q2r_E02340-000Dentalreportable segment | revenue | 2024-09-01 → 2025-02-28 | ¥4.5bn |
| jpcrp040300-q2r_E02340-000Dentalreportable segment | revenue external | 2024-09-01 → 2025-02-28 | ¥4.5bn |
| jpcrp040300-q2r_E02340-000Dentalreportable segment | segment profit | 2024-09-01 → 2025-02-28 | ¥460m |
| jpcrp040300-q2r_E02340-000Eyeless Needlereportable segment | revenue | 2024-09-01 → 2025-02-28 | ¥5.6bn |
| jpcrp040300-q2r_E02340-000Eyeless Needlereportable segment | revenue external | 2024-09-01 → 2025-02-28 | ¥5.6bn |
| jpcrp040300-q2r_E02340-000Eyeless Needlereportable segment | revenue intersegment | 2024-09-01 → 2025-02-28 | ¥0 |
| jpcrp040300-q2r_E02340-000Eyeless Needlereportable segment | segment profit | 2024-09-01 → 2025-02-28 | ¥2.1bn |
| jpcrp040300-q2r_E02340-000Surgicalreportable segment | revenue | 2024-09-01 → 2025-02-28 | ¥4.7bn |
| jpcrp040300-q2r_E02340-000Surgicalreportable segment | revenue external | 2024-09-01 → 2025-02-28 | ¥4.7bn |
| jpcrp040300-q2r_E02340-000Surgicalreportable segment | segment profit | 2024-09-01 → 2025-02-28 | ¥1.6bn |
| Total Of Reportable Segments And Otherssegment total | revenue | 2024-09-01 → 2025-02-28 | ¥14.8bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2024-09-01 → 2025-02-28 | ¥14.8bn |
| Total Of Reportable Segments And Otherssegment total | revenue intersegment | 2024-09-01 → 2025-02-28 | ¥0 |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2024-09-01 → 2025-02-28 | ¥4.2bn |
| Reconciling Itemsreconciling | revenue | 2023-09-01 → 2024-02-29 | ¥0 |
| Reconciling Itemsreconciling | revenue intersegment | 2023-09-01 → 2024-02-29 | ¥0 |
| jpcrp040300-q2r_E02340-000Dentalreportable segment | revenue | 2023-09-01 → 2024-02-29 | ¥5.1bn |
| jpcrp040300-q2r_E02340-000Dentalreportable segment | revenue external | 2023-09-01 → 2024-02-29 | ¥5.1bn |
| jpcrp040300-q2r_E02340-000Dentalreportable segment | segment profit | 2023-09-01 → 2024-02-29 | ¥1.0bn |
| jpcrp040300-q2r_E02340-000Eyeless Needlereportable segment | revenue | 2023-09-01 → 2024-02-29 | ¥5.0bn |
| jpcrp040300-q2r_E02340-000Eyeless Needlereportable segment | revenue external | 2023-09-01 → 2024-02-29 | ¥5.0bn |
| jpcrp040300-q2r_E02340-000Eyeless Needlereportable segment | revenue intersegment | 2023-09-01 → 2024-02-29 | ¥0 |
| jpcrp040300-q2r_E02340-000Eyeless Needlereportable segment | segment profit | 2023-09-01 → 2024-02-29 | ¥1.9bn |
| jpcrp040300-q2r_E02340-000Surgicalreportable segment | revenue | 2023-09-01 → 2024-02-29 | ¥3.8bn |
| jpcrp040300-q2r_E02340-000Surgicalreportable segment | revenue external | 2023-09-01 → 2024-02-29 | ¥3.8bn |
| jpcrp040300-q2r_E02340-000Surgicalreportable segment | segment profit | 2023-09-01 → 2024-02-29 | ¥1.2bn |
| Total Of Reportable Segments And Otherssegment total | revenue | 2023-09-01 → 2024-02-29 | ¥13.9bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2023-09-01 → 2024-02-29 | ¥13.9bn |
| Total Of Reportable Segments And Otherssegment total | revenue intersegment | 2023-09-01 → 2024-02-29 | ¥0 |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2023-09-01 → 2024-02-29 | ¥4.2bn |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 507
| Item | Context | Value | Unit |
|---|---|---|---|
| Footnotes regarding segment information table (text) | Prior1YTDDuration | Text · Plus | |
| Footnotes regarding segment information table (text) | CurrentYTDDuration | Text · Plus | |
| Notes revenue recognition quarterly consolidated financial statements (text) | CurrentYTDDuration | Text · Plus | |
| Notes per share information quarterly consolidated financial statements (text) | CurrentYTDDuration | Text · Plus | |
| Notes significant events after reporting period quarterly consolidated financial statements (text) | CurrentYTDDuration | Text · Plus | |
| Other information consolidated financial statements etc (text) | CurrentYTDDuration | Text · Plus | |
| Information about company which provides guarantee to reporting company (text) | FilingDateInstant | Text · Plus |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 14 of 14 passed
| balance sheet identity | pass rounding |
| balance sheet identity | pass |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |